Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme

Free Radical Biology & Medicine
Loren E WoldJun Ren

Abstract

Diabetic cardiomyopathy contributes to high morbidity and mortality in diabetic populations. It is manifested by compromised ventricular contraction and prolonged relaxation attributable to multiple causative factors including oxidative stress. This study was designed to examine the effect of cardiac overexpression of the heavy metal scavenger metallothionein (MT) on cardiac contractile function, intracellular Ca(2+) cycling proteins, stress-activated signaling molecules and the myosin heavy chain (MHC) isozyme in diabetes. Adult male wild-type (FVB) and MT transgenic mice were made diabetic by a single injection of streptozotocin (STZ). Contractile properties were evaluated in cardiomyocytes including peak shortening (PS), time-to-PS (TPS), time-to-relengthening (TR(90)), maximal velocity of shortening/relengthening (+/-dL/dt) and intracellular Ca(2+) fluorescence. Diabetes significantly depressed PS, +/-dL/dt, prolonged TPS, TR(90) and intracellular Ca(2+) clearing, elevated resting intracellular Ca(2+), reduced caffeine-induced sarcoplasmic reticulum Ca(2+) release and dampened stress tolerance at high stimulus frequencies. MT itself exhibited little effect on myocyte mechanics but it significantly alleviated STZ-induced myo...Continue Reading

References

Apr 1, 1997·Cardiovascular Research·S W SchafferS N Allo
Jul 11, 2000·Journal of Molecular and Cellular Cardiology·C DepreH Taegtmeyer
Jan 24, 2002·Nature·Donald M Bers
Sep 6, 2002·Cardiovascular Toxicology·L Cai, Y J Kang
Sep 10, 2002·American Journal of Physiology. Endocrinology and Metabolism·Faye L NorbyJun Ren
Jan 18, 2003·American Journal of Physiology. Endocrinology and Metabolism·Jinhong DuanJun Ren
Mar 6, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Veronica L M RundellPieter P de Tombe
Nov 24, 2004·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Rocco BarazzoniGianfranco Guarnieri
Feb 16, 2005·Endocrine·Jun Ren, Asli F Ceylan-Isik
May 25, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Csaba Szabó
Jul 26, 2005·Acta Pharmacologica Sinica·Loren E WoldJun Ren

❮ Previous
Next ❯

Citations

May 12, 2010·Cardiovascular Toxicology·Guy Vassort, Belma Turan
Jul 4, 2012·Antioxidants & Redox Signaling·Min ZhangAjay M Shah
Feb 26, 2014·BMC Bioinformatics·Víctor MartínezArmando Blanco
Feb 28, 2013·Heart Failure Reviews·Michael IsfortLoren E Wold
Jan 31, 2014·Diabetologia·Heiko Bugger, E Dale Abel
Jun 1, 2011·Heart Failure Reviews·Inês Falcão-Pires, Adelino F Leite-Moreira
May 12, 2015·Diabetes/metabolism Research and Reviews·Yinjie SuChaojun Zhang
Jul 20, 2010·Journal of Molecular and Cellular Cardiology·Gretel MonrealMark A Gerhardt
Mar 24, 2010·Chemico-biological Interactions·Sameer GoyalDharamvir Singh Arya
Jun 13, 2009·Best Practice & Research. Clinical Endocrinology & Metabolism·Kaivan KhavandiRayaz A Malik
Apr 28, 2009·Journal of Diabetes and Its Complications·Frank Christopher HowarthMilos Ljubisavljevic
May 20, 2015·Journal of Molecular and Cellular Cardiology·Sarah C W StevensLoren E Wold
Mar 30, 2007·Journal of Pharmacological and Toxicological Methods·Pitchai BalakumarManjeet Singh
Nov 20, 2014·Hämostaseologie·H Bugger, C Bode
Sep 23, 2008·British Journal of Pharmacology·N YarasR Schulz
Mar 23, 2007·Annals of the New York Academy of Sciences·Xia Shen, Karin E Bornfeldt
Nov 26, 2014·Journal of Diabetes Investigation·Quan LiuLu Cai
Jun 19, 2013·Clinical Science·Yves Gorin, Karen Block
Mar 19, 2014·Journal of Molecular and Cellular Cardiology·Jillian N SimonRicardo Carnicer
Dec 17, 2010·Journal of Translational Medicine·Yuwei ZhangWei-Ping Min
Apr 21, 2009·Journal of Molecular and Cellular Cardiology·Ashwin AkkiAjay M Shah
Jul 5, 2016·International Journal of Molecular Sciences·Shudong WangYang Zheng
Apr 5, 2017·Journal of Molecular Endocrinology·Rebecca H RitchieAnna C Calkin
Jan 7, 2015·Circulation. Heart Failure·Helen M ParryChim C Lang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.